News
1h
Zacks Investment Research on MSNHims & Hers vs. LifeMD: Which Telehealth Stock Has More Upside?Virtual healthcare services, or telehealth, are rapidly becoming a standard of care in the expanding digital healthcare space ...
Novo Nordisk just killed its deal with Hims & Hers. But Hims might come out stronger after this development. Read why the ...
23h
24/7 Wall St. on MSN7 Killer European Stocks To Buy In JulyAs you look at the stock markets around the world, it’s always a balance of trying to decide when is the right time to buy.
Gyre Therapeutics has a unique business model for evaluating and commercializing drugs in China. Find out why GYRE stock is a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results